GlassScriptPhysician profile
Matthew Bruntel
NPI 1114102134
$701.30
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.06 · 2021: $104 · 2022: $211 · 2023: $279 · 2024: $69.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $104.00 | 2022-2023 | Qulipta, Vraylar |
| Daiichi Sankyo INC. | $80.04 | 2021-2023 | Injectafer |
| Viiv Healthcare Company | $78.17 | 2022-2023 | Apretude |
| Pfizer INC. | $66.25 | 2023-2024 | |
| Exact Sciences Corporation | $54.94 | 2023-2024 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $44.07 | 2022-2024 | Contrave, Onzetra Xsail |
| Merck Sharp & Dohme LLC | $41.37 | 2022-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Biohaven Pharmaceutical Holding Company LTD. | $34.65 | 2022 | |
| Sunovion Pharmaceuticals INC. | $33.82 | 2021 | |
| Idorsia Pharmaceuticals US INC | $22.87 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.67 | 2023 | Airduo Digihaler |
| Amgen INC. | $20.53 | 2021 | |
| Acadia Pharmaceuticals INC | $19.33 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $19.25 | 2021 | |
| Lilly USA, LLC | $17.99 | 2023 | Mounjaro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $17.73 | 2019 | |
| Novo Nordisk INC | $12.98 | 2023 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bruntel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.